Concord Biotech shares list at a healthy premium. What should investors do?

Concord Biotech is a biotechnology company and a leading maker of select fermentation-based APIs across immunosuppressants and oncology in terms of market share, based on volume in 2022.
Read More

About The Author

Jonathan Jeriah

See author's posts